CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 21,400 full-time employees. The firm operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The firm conducts its business in the domestic and overseas markets.
CSPCY'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
CSPC Pharmaceutical Group Limited'in en son EPS'si $0.03 olup, $0.13 beklentilerini kazanmamak.
CSPC Pharmaceutical Group Limited CSPCY'ün son çeyrekteki geliri nasıl performans gösterdi?
CSPC Pharmaceutical Group Limited'in son çeyrek geliri $0.03
CSPC Pharmaceutical Group Limited'in gelir tahmini nedir?
4 Wall Street analistine göre, CSPC Pharmaceutical Group Limited'in gelir tahmini $11.79B ile $7.88B arasında değişmektedir.
CSPC Pharmaceutical Group Limited'in kazanç kalite puanı nedir?
CSPC Pharmaceutical Group Limited'in kazanç kalite puanı /'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
CSPC Pharmaceutical Group Limited kazançlarını ne zaman rapor eder?
CSPC Pharmaceutical Group Limited'in bir sonraki kazanç raporu 2026-06-23'te bekleniyor
CSPC Pharmaceutical Group Limited'in beklenen kazançları nelerdir?
Wall Street analistlerine göre CSPC Pharmaceutical Group Limited'in beklenen kazançları $8.66B'dir.
CSPC Pharmaceutical Group Limited kazanç beklentilerini aştı mı?
CSPC Pharmaceutical Group Limited'in son kazançları $6.11B olup, beklentileri kazanmaz.